Cross-linked hyaluronic acid 1.8%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cross-linked hyaluronic acid 1.8%, covering 2020-02-18 to 2020-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Clinical and Radiographic Parameters in the Application of Cross-linked Hyaluronic Acid 1.8% and Enamel Matrix Derivative in Periodontal Regeneration. [Phase 4]